Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Future Oncology (London, England)|February 7, 2024
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice?Michele Maffezzoli, Sebastiano Buti
Oncology Research|June 26, 2026
Engineering the Future of ADCs in Non-Small Cell Lung CancerMi Rim Kim, Jason Lau, Michele Maffezzoli, et al.
Current Oncology Reports|November 1, 2025
Who Truly Benefits From First-Line Intensification in EGFR-Mutant NSCLC?Michele Maffezzoli, Jason Lau, Samuel Justin, et al.
Immunotherapy|November 21, 2022
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinibGiulia Airò, Michele Maffezzoli, Alessandro Lazzarin, et al.
Oncology Research|January 8, 2026
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic ReviewGiacomo Iovane, Luca Traman, Michele Maffezzoli, et al.
Technology in Cancer Research & Treatment|March 25, 2025
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell CarcinomaMichele Maffezzoli, Alessio Signori, Davide Campobasso, et al.
Technology in Cancer Research & Treatment|March 1, 2023
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic ScenarioGiulia Mazzaschi, Giulia Claire Giudice, Matilde Corianò, et al.
Critical Reviews in Oncology/Hematology|March 2, 2026
When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinomaSebastiano Buti, Betty Dalla Valle, Alessandro Acunzo, et al.
Oncology Research|April 7, 2025
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative reviewMichele Maffezzoli, Giulia Claire Giudice, Giacomo Iovane, et al.
Expert Review of Anticancer Therapy|February 11, 2025
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated reviewGiulia Claire Giudice, Michele Maffezzoli, Irene Testi, et al.
Pageof 3